Antibody Drug Conjugate Market: Bridging Biologics and Chemotherapy
The medical community is moving away from the "one-size-fits-all" approach of systemic chemotherapy, placing the Antibody Drug Conjugate Market at the forefront of modern precision medicine. By utilizing a "lock and key" mechanism, ADCs ensure that toxic payloads are only released once they reach the tumor site, minimizing collateral damage to healthy tissues. This level of selectivity is a...
0 Comentários 0 Compartilhamentos 3 Visualizações
Aldyra https://aldyra.com